RxDoctor Payments Data

Stephen Woof, PA

Physician Assistant · Fredericksburg, VANPI 1396739835

Payments from drug & device makers

$6,830in general payments, 2019–2025

Across 379 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • Pfizer$671
  • Lilly USA, LLC$492
  • Amgen$399
  • Abbott$347
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$6,813100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,830 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$43,652
Medicare patients
185
Services billed
646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin68$98,706
EliquisApixaban84$93,428
OzempicSemaglutide57$66,375
TrulicityDulaglutide27$50,601
XareltoRivaroxaban27$34,816
JanuviaSitagliptin Phosphate28$28,968
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$27,740
MounjaroTirzepatide15$16,429
FarxigaDapagliflozin Propanediol14$15,476
Spiriva HandihalerTiotropium Bromide11$7,517
Lurasidone Hcl11$6,443
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$6,190
Aripiprazole28$4,514
VascepaIcosapent Ethyl11$3,809
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$301$98,70668 claims
PfizerEliquis$671$93,42884 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$492$68,64053 claims
Novo NordiskOzempic$1,039$66,37557 claims
Johnson & JohnsonXarelto$41$34,81627 claims
MerckJanuvia$122$28,96828 claims
GSKTrelegy Ellipta$207$27,74019 claims
AstraZenecaFarxiga$228$15,47614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →